Medical Science Liaisons (MSLs) serve as the bridge between pharmaceutical companies, healthcare professionals, and the scientific community. Their impact reverberates across the entire healthcare ecosystem as they are essential for fostering scientific dialogue, driving evidence-based medicine, and advancing patient outcomes.
Impact on Newly-Launched Products
In her latest article Susan Giacalone, EVERSANA’s Vice President of Medical Deployment highlights the significant impact MSLs can have on the success trajectory of newly-launched products. The article also includes a case study that demonstrates how a robust medical affairs operation and MSL team helped build a strategic partnership to overcome industry challenges. Specifically, the case study details how an emerging biotech company leveraged EVERSANA’s Oncology Center of Excellence to establish a comprehensive medical affairs infrastructure for the launch of a stem cell mobilizing agent. This collaboration ensured a timely, organized, and strategic approach to the medical launch plan, resulting in heightened product awareness, significant advocacy with priority KOLs, and practical go-to-market readiness.
Key Elements for High-Impact Medical Affairs and MSL Teams
The article further discusses three key elements necessary to establish high-impact Medical Affairs and MSL teams:
- Strategic Partnership: To excel in the competitive pharmaceutical arena, manufacturers need a commercialization ally that transcends the conventional model. Look for a partner with proven subject matter expertise that not only provides bodies but also offers the ability to create and mobilize strategies tailored to your specific needs.
- Cross-Collaboration: A strong culture of cross-collaboration within your organization is imperative. Forge synergistic relationships with internal teams such as Health Economics and Outcomes Research (HEOR), Value and Evidence, and Market Access.
- Business Acumen: Equip your MSL teams with a nuanced understanding of business dynamics, enabling them to effectively communicate value propositions and align their efforts with strategic objectives.
By embracing these principles, manufacturers can effectively navigate the complexities of product launches, foster innovation, and ultimately drive success in delivering value to both patients and stakeholders.
To gain a deeper understanding of these concepts and explore the full breadth of insights, complete the form to download the full article.
Author
Susan leads field medical efforts for EVERSANA. As a leader in the life sciences industry, she brings more than 20 years of medical affairs experience across multiple therapeutic areas, including oncology, hepatology and rare…